A stack combines several products in pursuit of a broad goal. In older adults, that approach can increase uncertainty about interactions, adverse effects and which ingredient is responsible for any change. Calling the combination anti-aging does not give it a defined clinical endpoint.

More ingredients create more unanswered questions

A study of one compound cannot establish the safety of that compound combined with several others. Changes in appetite, glucose regulation, fluid balance or symptoms may be difficult to attribute. If multiple products are started together, both improvement and harm become harder to interpret.

FDA notes that older adults can face increased interaction risk as their bodies and medicine use change. NIA emphasizes reviewing prescription medicines, over-the-counter products and supplements together with a healthcare professional. A peptide sold as a research material should not be omitted from that discussion if someone has used it. FDA medicines and aging NIA taking medicines safely as you age

Longevity requires more than a biomarker

An anti-aging claim might imply longer life, fewer diseases or better daily function. A shift in a laboratory value does not establish those outcomes. FTC guidance requires scientific support for the health message consumers actually receive, including implied promises. FTC Health Products Compliance Guidance

A credible combination trial would define its population and primary outcome, use characterized products, compare the combination appropriately and collect harms over a relevant period. It would also need to address whether any benefit is attributable to one component rather than the entire stack.

AXON should not present a combination as a shortcut around those requirements. This review did not verify an anti-aging peptide stack with evidence sufficient for a general recommendation to seniors. The educational conclusion is to reduce ambiguity: identify the actual health concern, review all exposures and judge each claim against direct human evidence. No administration plan or advice to alter prescribed treatment is provided.